AI news that drew views this week (March 1-5)

Clinical laboratories store a motherlode of objective and structured patient data well primed for mining with AI. Given this reality, pathologists and medical laboratorians must set and abide by principles guiding the ethical use of the technology.

Researchers in Italy have demonstrated a no-cost, AI-based technique for detecting the presence of previously undiagnosed abnormalities in blood sugar stability.

The reported exploration to sell Watson Health, the AI-driven health business of IBM, underscores deep challenges with technology in solving healthcare problems, according to the Wall Street Journal.

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.

Emergency-room patients are happy to receive care from a physician interacting remotely over a tablet computer mounted on a dog-like robot.

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.

Harvard researchers have used machine learning to find molecular features in existing drugs that may be effective in warding off or treating Alzheimer’s disease.